CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million
CareDx will acquire Naveris for $160 million, adding a Medicare-reimbursed liquid biopsy platform for viral-mediated cancer monitoring to its precision medicine portfolio.
Tag: biomarkers
All
Latest
All
Latest
Maternal Blood Test Identifies Autoantibodies Linked to Autism Subtype
The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.
All
Latest
Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer
Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.
ADDF Launches Third Phase of Diagnostics Accelerator with $50 Million to Advance Alzheimer’s Blood Tests and AI Biomarkers
The new funding brings the initiative’s total to $150 million and will focus on tau pathology, multi-marker panels, and AI-driven diagnostics.
Read More
Siemens Healthineers Expands Brain Health Research Portfolio with New Blood-Based Tau Assays
Siemens Healthineers has introduced two new blood-based tau assays for research use on the Atellica platform, expanding its brain health portfolio with tests aimed at advancing neurodegenerative disease research.
Read More
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
The test identifies carriers of a genetic variant found in up to 60% of Alzheimer’s patients, helping clinicians triage patients and guide treatment decisions.
Read More
NIH Awards $2.5 Million to Advance Eye-Based Detection of ALS Biomarker TDP-43
The Phase 2 grant supports AI-driven analysis of retinal tissue to identify disease-specific patterns linked to ALS, FTD, and LATE.
Read More
Blood Test for Endometriosis Detection Validated in Multi-Center Clinical Study
A peer-reviewed study in the Journal of Minimally Invasive Gynecology found HerAnova’s HerResolve blood assay detected 61.5% of endometriosis cases missed by imaging, with 97.5% specificity and 80% sensitivity.
Read More
Deep Learning Pathology Models Caught ‘Cheating,’ Study Finds
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Read More
Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening
A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.
Read More
New Systems Biology Approach Improves Cancer Diagnosis Using Multi-Omic Data
Researchers at Yeditepe University have developed a machine learning classifier that integrates multi-omic data and metabolic modeling, improving lung and pancreatic cancer diagnosis accuracy, according to a study in Quantitative Biology.
Read More
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test
The test uses five biomarkers and proprietary technology to detect amyloid brain plaques in patients with cognitive symptoms.
Read More
Circular Genomics Secures Exclusive Rights to Blood Test Technology for Alzheimer’s Disease
Circular Genomics has secured exclusive rights from Washington University and Max Delbrück Center to develop a blood-based Alzheimer’s test using circular RNA biomarkers.
Read More
PathAI Launches AI Tools for Inflammatory Bowel Disease Clinical Trials
PathAI has launched new AI-powered tools on its AISight Clinical Trials Platform, providing standardized histopathology endpoints for inflammatory bowel disease drug development.
Read More
Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read More
New Test Strip Detects Cancer Biomarkers at Ultra-Low Concentrations
Researchers at La Trobe University have developed a single-use test strip that detects cancer-related microRNAs in blood plasma at concentrations up to 1,000 times lower than current methods.
Read More
Blood Test Identifies Lung Cancer Patients Who Will Respond to Immunotherapy
Researchers at Mass General Brigham have developed a blood test that predicts tarlatamab response in small cell lung cancer, showing 85% sensitivity and 100% specificity.
Read More
Researchers Identify Four New Markers for Detecting Aggressive Breast Cancer Cells in Blood
Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.
Read More